PMID: 11900096Mar 20, 2002Paper

Employer-sponsored health insurance: pressing problems, incremental changes

Health Affairs
S TrudeAndrea M Benoit

Abstract

Despite large premium increases, employers made only modest changes to health benefits in the past two years. By increasing copayments and deductibles and changing their pharmacy benefits, employers shifted costs to those who use services. Employers recognize these changes as short-term fixes, but most have not developed strategies for the future. Although interested in "defined-contribution" benefits, employers do not agree about what this entails and have no plans for moving to defined contributions in the near future. While dramatic changes in health benefits are unlikely in the short term, policymakers may want to watch for future erosions in health coverage.

References

Feb 24, 2001·Health Affairs·C HoganJ R Gabel
Mar 20, 2002·Health Affairs·Debra A DraperBradley C Strunk

❮ Previous
Next ❯

Citations

Sep 20, 2002·The New England Journal of Medicine·John K Iglehart
Nov 30, 2006·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Nicholas H WoolfMichael C Fiore
Aug 1, 2002·Expert Review of Pharmacoeconomics & Outcomes Research·William E Encinosa
Mar 26, 2003·Health Services Research·Cara S LesserKelly J Devers
Mar 26, 2003·Health Services Research·Jon B Christianson, Sally Trude
Mar 26, 2003·Health Services Research·Kelly J DeversTimothy K Lake
Sep 11, 2008·Health Affairs·Jon B ChristiansonDebra A Draper
Jan 17, 2003·Health Affairs·Carolyn WattsSally Trude
Apr 20, 2006·Health Affairs·Robert E HurleyJeremy Pickreign
Nov 22, 2002·Health Affairs·Lauren A McCormackJeremy Pickreign
Mar 20, 2002·Health Affairs·Debra A DraperBradley C Strunk
Aug 7, 2002·Circulation·David E Kandzari, Daniel B Mark
Apr 22, 2003·Health Affairs·Jason S Lee, Laura Tollen
Sep 15, 2009·Journal of Occupational and Environmental Medicine·Xuguang TaoEdward J Bernacki
Dec 14, 2011·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Carolyn S DewaPhillip Jacobs
Feb 11, 2003·Nursing Management·Tim Porter-O'Grady
Jan 7, 2006·Pediatrics·Susan K SchmittCiaran S Phibbs

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.